Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China flag China · Delayed Price · Currency is CNY
55.87
+4.37 (8.49%)
Jul 10, 2026, 3:00 PM CST

Chengdu Easton Biopharmaceuticals Company Description

Chengdu Easton Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of pharmaceutical products in China and internationally.

The company offers active pharmaceutical ingredients; finished dosage forms, including capsules, tablets, and injections; pharmaceutical intermediates; biological drugs; and generic drugs.

Its products are used in oncology, cardiovascular, neurology and psychiatry, anesthetic and analgesics, urinary, anti-inflammatory, anti-diabetes, anthelmintic, and antiemetic therapeutic categories.

The company was founded in 2009 and is headquartered in Chengdu, China.

Chengdu Easton Biopharmaceuticals Co., Ltd.
CountryChina
Founded2009
IndustryBiotechnology
SectorHealthcare
Employees1,480
CEOMingxu Yuan

Contact Details

Address:
No. 8, Ankang Road
Chengdu, 610200
China
Phone86 28 8782 7191
Websiteeastonpharma.cn

Stock Details

Ticker Symbol688513
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100004397
SIC Code2834

Key Executives

NamePosition
Mingxu YuanGM and Director
Xiao Qin BoChief Financial Officer, Accounting Supervisor and Director
Daming ZhangDeputy GM and Director
Shuyun LiBoard Secretary
Zheng Pin GuanDeputy GM and Core Technician
Xingyao SongDeputy General Manager
Avinash Ramkisan ManeChief Scientist of Formulation Research Department and Core Technician
Haibin GuoManager of Formulation Research Department and Core Technician